Skin angiosarcoma
MONDO:0003029A malignant vascular neoplasm arising from the skin.
Also known as: angiosarcoma (disease) of zone of skin, angiosarcoma of skin, angiosarcoma of the skin, hemangiosarcoma of skin, hemangiosarcoma of the skin, skin angiosarcoma, skin hemangiosarcoma, zone of skin angiosarcoma (disease)
2842 clinical trials for this condition and its sub-types, 6 tagged with Skin angiosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Personalized cancer vaccine trial for rare skin cancer withdrawn before starting
Vaccine CancelledThis study aimed to find a safe dose of a custom-made mRNA vaccine for people with a rare skin cancer called cutaneous angiosarcoma. The vaccine was designed to train the immune system to attack the cancer. However, the trial was withdrawn before any participants were enrolled.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
New hope for rare cancer: immune booster plus chemo shows promise
Disease control OngoingThis phase II trial tests whether adding the immunotherapy drug nivolumab to the chemotherapy paclitaxel helps shrink tumors in people with angiosarcoma who haven't had taxane drugs before. For those who have already received taxanes, the trial tests a combination of nivolumab an…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Cancer-Killing virus paired with immunotherapy shows promise in sarcoma trial
Disease control OngoingThis phase 2 study tests a combination of two drugs—talimogene laherparepvec (T-VEC), a virus that attacks cancer cells, and pembrolizumab, an immunotherapy that helps the immune system fight cancer—in 41 adults with advanced sarcoma that has spread or cannot be removed by surger…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New combo therapy shows promise for rare, aggressive skin cancer
Disease control OngoingThis study tests giving the chemotherapy drug paclitaxel before and during radiation therapy for people with cutaneous angiosarcoma, a rare and aggressive skin cancer. The goal is to shrink the tumor before surgery and improve how long patients live without the cancer coming back…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC